Felton's Robin Agar-Celli ships every hat herself, paying out of her own pocket. But it's the thousands of worldwide volunteers who fuel her dream.

Chinese regulators have accepted HUTCHMED's (HCM) application for priority review for the drug combination Orpathys and ...

This small cap ASX stock is having a strong finish to the week. What is getting investors excited today? Let's find out.

Starting in 2025, New Yorkers with private insurance will no longer face copays for insulin, thanks to a groundbreaking state ...

Before the law, there was no cap on what Medicare enrollees might have to spend on medications covered by their Part D drug ...

Cancer survival has dramatically increased, but chemotherapy can lead to lasting organ damage ... The stakes are high for Race, which has a market cap of around $240 million after this year’s 64% ...

Third graders in the After School Student Buddies Club at Niagara and Teacher Kara Cobb are behind the reindeer and other art projects specifically for chemotherapy patients. It’s the first club ...

Starting next year, Medicare recipients will see a $2,000 out-of-pocket cap on some prescription drugs as part of several new provisions coming in 2025. Starting in 2025, Medicare recipients will ...

Experts say the new cap could bring much-needed relief to cancer patients, who often face staggering medication expenses. 'The Cosby Show' actor Geoffrey Owens 'struggling' to make living as ...

The new price cap, part of the Inflation Reduction Act, will apply to all prescription drugs covered by Medicare.

Starting Jan. 1, older adults on Medicare will spend no more than $2,000 a year on prescription drugs when a new price cap on out-of-pocket payments from the Inflation Reduction Act goes into effect.